TY - GEN
T1 - Gender and arthroplasty type affect prevalence of moderate-severe pain post total hip arthroplasty
AU - Singh, J. A.
AU - Gabriel, S. E.
AU - Lewallen, D.
PY - 2009
Y1 - 2009
N2 - Objective: To investigate the impact of gender, age and arthroplasty type (primary vs. revision) on prevalence of moderate-severe hip pain. Methods: Using an Institutional Total Joint Registry, we identified a cohort of patients who underwent primary of revision THA from 1996-2004 and responded to the follow-up questionnaires. We compared the prevalence of moderate or severe hip pain based on arthroplasty type, gender and by age (<60, 61-70, 71-80 and >80 years). Results based on gender and type of arthroplasty were analyzed by comparing proportions and based on age by using Chi-square tests, considering a p-value<0.05 significant. Results: Moderate-severe pain was less prevalent following primary vs. revision THA at 1-year (5.5% vs. 9.8%, p<0.001), and 2-years post-surgery (7.5% vs. 16.3% vs.; p<0.001). The prevalence of moderate-severe pain at 1-year post-arthroplasty was similar for women and men, both primary THA and revision THA: 6.3% vs. 4.6%, p=0.13; and 11.8% vs. 7.3%, p=0.058, respectively; and in revision THA at 2-years: 17.7% vs. 14.7%, p=0.068. However at 2-years, more women than men had moderate-severe pain in primary THA group: 8.8% vs. 6.6%, p=0.042, respectively. Age had a significant impact on prevalence of moderatesevere pain after 1- and 2-years after primary THA with lower prevalence of pain in 61-70 yr age group compared to other age categories (p=0.01 and p<0.001), but did not have a significant impact on prevalence of moderate- severe pain postrevision THA (p=0.406 and p=0.397, respectively). Conclusions: Moderate-severe pain was more prevalent in women with primary THA at 2-years, but not at 1-year. This might suggest that factors not directly related to surgery such as anatomical and biochemical differences, bone remodeling, differences in recovery of strength and endurance, activity level or comorbidities may play a role in these differences and need further study.
AB - Objective: To investigate the impact of gender, age and arthroplasty type (primary vs. revision) on prevalence of moderate-severe hip pain. Methods: Using an Institutional Total Joint Registry, we identified a cohort of patients who underwent primary of revision THA from 1996-2004 and responded to the follow-up questionnaires. We compared the prevalence of moderate or severe hip pain based on arthroplasty type, gender and by age (<60, 61-70, 71-80 and >80 years). Results based on gender and type of arthroplasty were analyzed by comparing proportions and based on age by using Chi-square tests, considering a p-value<0.05 significant. Results: Moderate-severe pain was less prevalent following primary vs. revision THA at 1-year (5.5% vs. 9.8%, p<0.001), and 2-years post-surgery (7.5% vs. 16.3% vs.; p<0.001). The prevalence of moderate-severe pain at 1-year post-arthroplasty was similar for women and men, both primary THA and revision THA: 6.3% vs. 4.6%, p=0.13; and 11.8% vs. 7.3%, p=0.058, respectively; and in revision THA at 2-years: 17.7% vs. 14.7%, p=0.068. However at 2-years, more women than men had moderate-severe pain in primary THA group: 8.8% vs. 6.6%, p=0.042, respectively. Age had a significant impact on prevalence of moderatesevere pain after 1- and 2-years after primary THA with lower prevalence of pain in 61-70 yr age group compared to other age categories (p=0.01 and p<0.001), but did not have a significant impact on prevalence of moderate- severe pain postrevision THA (p=0.406 and p=0.397, respectively). Conclusions: Moderate-severe pain was more prevalent in women with primary THA at 2-years, but not at 1-year. This might suggest that factors not directly related to surgery such as anatomical and biochemical differences, bone remodeling, differences in recovery of strength and endurance, activity level or comorbidities may play a role in these differences and need further study.
KW - Age
KW - Gender
KW - Hip arthroplasty
KW - Pain
KW - Predictors
UR - http://www.scopus.com/inward/record.url?scp=84891949180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891949180&partnerID=8YFLogxK
U2 - 10.1007/978-3-540-92841-6_407
DO - 10.1007/978-3-540-92841-6_407
M3 - Conference contribution
AN - SCOPUS:84891949180
SN - 9783540928409
T3 - IFMBE Proceedings
SP - 1640
EP - 1643
BT - 13th International Conference on Biomedical Engineering - ICBME 2008
T2 - 13th International Conference on Biomedical Engineering, ICBME 2008
Y2 - 3 December 2008 through 6 December 2008
ER -